Angiogenesis Foundation Inc

Analysis

Angiogenesis Foundation Inc is a registered charity in United States, based in Cambridge, MA. It received its IRS tax-exemption ruling in October 1995, 31 years ago. Its declared purposes cover diseases, disorders and medical disciplines, which this site groups under health and saving lives. The IRS classifies it as a publicly supported organisation (donations from the general public) under section 501(c)(3), and contributions to it are listed as tax-deductible.

In the financial year ending March 2023, Angiogenesis Foundation Inc reported income of $959k and spending of $1.1m, spending 117% of what it took in. Across the 5 years on record, from March 2019 to March 2023, income fell from $2.5m to $959k (-61%), an average of -21% a year. The sharpest change came in the year to March 2022, when income rose by 93%. Over the whole period it spent 108% of the income it received.

Among 40,470 United States charities whose main cause is health and saving lives and that reported income, Angiogenesis Foundation Inc sits at the 64th percentile: it is larger than about 64% of them. Against every charity in United States with reported income it ranks in the 79th percentile, and in the 78th percentile within MA. Charities of a similar size with the same main cause include Michigan Association for Local Public Health ($959k), International Foot & Ankle Foundation for Edu & Research ($960k) and Southeastern Arizona Community Unique Services ($959k).

On its Form 990 for the period ending March 2023, revenue came from contributions and grants 94% and program service revenue 3.4% of the total. Compensation of current officers, directors and key employees was $623k (55% of expenses). Other salaries and wages came to $219k. At year end it held assets of $336k against liabilities of $508k, net assets of -$173k. It reported 7 employees.